Latest

psychopharmacology

Featured Genetics Neuroscience Psychology

·March 22, 2019·4 min read

When neurons are out of shape, antidepressants may not work

Differences in serotonergic neuron morphology, along with altered gene expression have been identified in patients with MDD. The findings shed light on why some patients do not respond to SSRI antidepressants.

Featured Neuroscience Psychology

·March 18, 2019·3 min read

Fast-acting psychedelic associated with improvements in depression/anxiety

5-MeO-DMT, a fast-acting synthetic psychedelic, shows promise for treating depression and anxiety. 80% of test subjects reported improvements in symptoms associated with depression and anxiety after taking the drug.

Featured Neuroscience Psychology

·February 25, 2019·3 min read

Ritalin Has No Effect on Primate Prefrontal Cortex

Even at doses that help improve monkeys' attention, researchers observe no differences of neural activity in the prefrontal cortex after administering Ritalin.

Featured Psychology

·February 22, 2019·5 min read

Combination Therapy May Be Beneficial For Schizophrenia Treatment

A new study reports combining antipsychotic medications could help to prevent relapse and hospitalization for those with schizophrenia. Combining aripiprazole and clozapine resulted in a 23% lower risk of re-hospitalization than with clozapine alone, researchers report.

Featured Neuroscience Psychology

·February 17, 2019·6 min read

Heartbeats and Memory Suppression: The New Tools for Controlling Fear

From designing drugs to help suppress traumatic memories, to harnessing the power of heartbeats, researchers are searching for new therapies to help people overcome their fears and phobias.

Featured Neuroscience Open Neuroscience Articles Psychology

·February 11, 2019·5 min read

Does Microdosing Improve Mood and Performance?

A new study reports those who microdose psychedelics report improvements in attention and mental health. However, a number of people report an increase in neuroticism following six weeks of microdosing.

Featured Neuroscience Psychology

·January 10, 2019·2 min read

Ketamine and Naltrexone Combo Shows Promise for Depression and Addiction Treatments

A new study reveals the combination of ketamine with naltrexone can help treat symptoms of both depression and addiction.

Featured Neuroscience Open Neuroscience Articles Psychology

·January 9, 2019·5 min read

Statins May Help Treat Serious Mental Illness

A new study reveals statins, biguanides and other drugs that help treat physical conditions may have significant benefits for the treatment of bipolar disorder and schizophrenia.